U.S. Beverage Stock News

NYSE:XZO
NYSE:XZOInsurance

Exzeo Group Flood Partnership Tests Valuation Concerns And Growth Hopes

Exzeo Group has entered into a new partnership with Tokio Marine Highland to distribute TMH2O residential flood insurance. The collaboration expands Exzeo’s property insurance offerings and supports its ambitions as a multi-line, technology driven platform. For investors tracking NYSE:XZO, this announcement comes as the stock trades at $16.1, with a 3.7% gain over the past week and a 20.8% decline over the past month. Year to date, shares show a 29.3% decline, so this move may stand out as...
NasdaqGS:ARHS
NasdaqGS:ARHSSpecialty Retail

Arhaus (ARHS) Valuation Check After Recent Share Price Pullback

Why Arhaus Stock Is Drawing Attention Now Arhaus (ARHS) has pulled back recently, with the share price down over the past month and past 3 months. This move is prompting investors to reassess how its current valuation lines up with the underlying business. The company reports annual revenue of US$1,379.2m and net income of US$67.3m, and some models suggest the shares trade at a sizeable discount to certain intrinsic value estimates. This can attract interest from value oriented investors. See...
NasdaqCM:USAU
NasdaqCM:USAUMetals and Mining

Is U.S. Gold (USAU) Using Its Conference Spotlight To Recast Management Credibility With Investors?

U.S. Gold Corp. recently presented at the Emerging Growth Virtual Conference on February 25, 2026, with Executive Chairman Luke Anthony Norman addressing investors. This appearance gave the company a platform to highlight its latest corporate developments and project plans directly to a broad investment audience. We’ll now explore how U.S. Gold Corp.’s Emerging Growth Virtual Conference presentation could shape its investment narrative and investor expectations. The best AI stocks today may...
NYSE:DTM
NYSE:DTMOil and Gas

What DT Midstream (DTM)'s Strong 2025 Results and Bigger Project Pipeline Mean For Shareholders

DT Midstream, Inc. reported full-year 2025 results showing sales rising to US$1,243 million and net income to US$441 million, alongside a 7% dividend increase to US$0.88 per share and a US$396.99 million shelf registration for 3,000,000 shares related to its ESOP. Management’s disclosure that its project pipeline is several times larger than the announced US$3.40 billion capital plan, with growth expected to outpace a 7% annualized rate through the rest of the decade, points to a materially...
NasdaqGS:OLPX
NasdaqGS:OLPXPersonal Products

A Look At Olaplex Holdings (OLPX) Valuation After The No.3PLUS Complete Repair Treatment Launch

What the No.3PLUS launch could mean for Olaplex Holdings (OLPX) Olaplex Holdings (OLPX) has launched No.3PLUS Complete Repair Treatment, a pre-shampoo product built on its Bond Building Technology and new Damage Defense Cationic Complex, supported by a broad retail rollout and a science themed marketing campaign. See our latest analysis for Olaplex Holdings. Despite today’s 5.6% one day share price decline, Olaplex’s 90 day share price return of 36.9% and 12.6% year to date gain suggest...
NYSE:BBU
NYSE:BBUIndustrials

Should Bullish Analyst Coverage on BBU’s Valuation Reframe How Investors Read Brookfield Business Partners’ Dealmaking Ambitions?

In recent days, CIBC initiated coverage on Brookfield Business Partners L.P. with an Outperformer rating, joining other brokers that have expressed confidence in the business. Analysts have highlighted Brookfield Business Partners’ connection to the broader Brookfield group, its cornerstone Clarios holding, and an apparent discount to net asset value as central to their positive view. We will now look at how this wave of bullish analyst coverage, especially around valuation and dealmaking...
NasdaqCM:VRRM
NasdaqCM:VRRMProfessional Services

Why Verra Mobility (VRRM) Is Down 10.1% After Strong 2025 Results And Major Hawaii Contract

Verra Mobility recently reported past fourth-quarter and full-year 2025 results showing higher revenue of US$257.86 million and US$979.08 million respectively, alongside a swing to net income of US$18.88 million for the quarter and US$136.63 million for the year. The company also secured a 10-year, approximately US$160 million statewide automated traffic enforcement contract with the Hawaii Department of Transportation, signaling a long-duration stream of enforcement-related service...
NYSE:EPAM
NYSE:EPAMIT

EPAM’s Empathy Lab North America Launch Puts AI Growth In Focus

EPAM Systems (NYSE:EPAM) has launched its AI-native marketing agency, Empathy Lab, in North America following its first year in Europe. The company has appointed Ben Hall to lead Empathy Lab's North American operations and guide its AI-driven growth offering for brands. The expansion is focused on building intelligent, human-centered growth systems that combine data, creative content, and AI for next-generation marketing. For EPAM Systems, known for its digital engineering and consulting...
NYSE:GHC
NYSE:GHCConsumer Services

Is Graham Holdings (GHC) Offering Value After Recent Share Price Weakness?

If you have been wondering whether Graham Holdings at around US$1,049 per share is still fairly priced or potentially offering value, you are not alone. The stock is currently around US$1,049.19, with a 7 day return of a 1.9% decline, a 30 day return of a 10.1% decline, a year to date return of a 3.5% decline, and a 1 year return of 9.3%, while the 3 year and 5 year returns sit at 73.1% and 85.9% respectively. Recent news coverage around Graham Holdings has largely focused on its identity as...
NasdaqGS:SABR
NasdaqGS:SABRHospitality

Assessing Sabre (SABR) Valuation After Shift To Positive Full Year Earnings

Why Sabre stock is drawing fresh attention after its latest earnings Sabre (SABR) has moved back into the spotlight after reporting fourth quarter and full year 2025 results that shifted the company from a net loss to positive net income for the year. For investors tracking travel technology names, that change in profitability and earnings per share, alongside ongoing quarterly losses, raises fresh questions about how to weigh Sabre’s recent performance against its longer term return...
NasdaqGS:UPBD
NasdaqGS:UPBDSpecialty Retail

A Look At Upbound Group (UPBD) Valuation As 2025 Results And 2026 Guidance Shape Expectations

Upbound Group (UPBD) is back in focus after its fourth quarter and full year 2025 earnings, where higher sales and revenue came alongside lower net income, and new 2026 revenue guidance between US$4.7b and US$4.95b. See our latest analysis for Upbound Group. The latest earnings release and 2026 revenue guidance have arrived alongside a 10.48% 1 month share price return and a 15.74% 3 month share price return, yet the 1 year total shareholder return of 10.15% and 5 year total shareholder...
NYSE:FN
NYSE:FNElectronic

Fabrinet’s AI Networking Role Brings Growth Potential And Concentration Risks

Fabrinet (NYSE:FN) is gaining attention for its growing role in AI infrastructure through partnerships that support high speed optical networking for AI data centers. The company is working with major technology players, including Nvidia and Amazon, to manufacture and assemble components that help move data efficiently inside AI workloads. This expanding role places Fabrinet closer to the core of AI hardware supply chains as demand for faster networking solutions tied to AI training and...
NasdaqGS:CHDN
NasdaqGS:CHDNHospitality

Marshall Yards Opening Tests Churchill Downs’ Gaming Growth And Earnings Quality

Churchill Downs (NasdaqGS:CHDN) has opened Marshall Yards Racing & Gaming, its eighth historical horse racing entertainment venue in Kentucky. The new property adds gaming and entertainment capacity while supporting purse funding for associated racing meets. For investors tracking Churchill Downs, the opening of Marshall Yards comes at a time when the stock trades at $93.78, with a value score of 6. Over longer periods, returns have been weak, with the share price down 18.2% over the past...
NYSE:INSP
NYSE:INSPMedical Equipment

Why Inspire Medical Systems (INSP) Is Up 11.2% After CMS Clarifies Coding For Inspire V

In late February 2026, the Centers for Medicare & Medicaid Services confirmed it will assign specific C-codes for Inspire Medical Systems’ Inspire V device in an upcoming outpatient coding update, resolving longstanding reimbursement uncertainties for its hypoglossal nerve stimulation therapy for obstructive sleep apnea. This coding clarification is important because it simplifies hospital and ambulatory surgery center billing, may improve payment predictability, and could make it easier for...
NasdaqGS:TFSL
NasdaqGS:TFSLBanks

Is TFS Financial (TFSL) Pricing In Too Much Optimism After Recent Regional Bank Focus?

If you are wondering whether TFS Financial is offering fair value at today’s price, you are not alone. This article is designed to help you weigh what the current share price might be implying. The stock most recently closed at US$14.33, with returns of 0.8% over 7 days, 1.8% over 30 days, 5.6% year to date, 17.9% over 1 year, 31.8% over 3 years and a 2.6% decline over 5 years. Recent news around TFS Financial has focused on its position as a regional bank and its role in the broader US...
NYSE:AMBP
NYSE:AMBPPackaging

A Look At Ardagh Metal Packaging (AMBP) Valuation After Earnings Beat, Green Bond Refi And Dividend Update

Ardagh Metal Packaging (AMBP) has given investors plenty to think about after reporting 2025 results that exceeded its own guidance, outlining 2026 adjusted EBITDA growth expectations, completing a US$1.3b green bond refinancing, and affirming a quarterly dividend. See our latest analysis for Ardagh Metal Packaging. The recent earnings beat, 2026 EBITDA guidance and US$1.3b green bond refinancing sit against a share price of US$4.85, with a 30 day share price return of 10.48% and a 1 year...
NasdaqGS:GENB
NasdaqGS:GENBBiotechs

Assessing Generate Biomedicines (GENB) Valuation After Recent Share Price Volatility

Event overview and immediate context Generate Biomedicines (GENB) recently drew investor attention after a single day move of about 3.8% and a year to date return of roughly a 23.9% decline, prompting closer scrutiny of its drug discovery model and early stage pipeline. See our latest analysis for Generate Biomedicines. For now, the 1 day share price return of about 3.8% and year to date share price return of roughly a 23.9% decline suggest sentiment has cooled, even as interest in its...
NYSE:LCII
NYSE:LCIIAuto Components

LCI Industries Leans On Acquisitions To Broaden Growth Beyond RV Cycle

LCI Industries (NYSE:LCII) has signaled ongoing interest in acquisitions, highlighting a renewed focus on M&A within its core markets. The company referenced a history of completed deals and expressed intentions to build on recent M&A momentum. This more active approach to acquisitions could influence LCI Industries' growth path, competitive position and capital deployment priorities. For investors watching NYSE:LCII, the renewed emphasis on acquisitions comes as the shares trade at...
ARCA:ESBA
ARCA:ESBAREITs

Empire State Realty OP (ESBA) FFO Loss Challenges Bullish Narratives After FY 2025 Results

Empire State Realty OP (ESBA) just wrapped up FY 2025 with Q4 total revenue of US$199.7 million and basic EPS of US$0.13, while trailing twelve month revenue sits at US$768.3 million and EPS at US$0.27. Over the past few quarters, revenue has moved from US$197.6 million in Q4 2024 to US$199.7 million in Q4 2025, with quarterly EPS shifting from US$0.07 to US$0.13. This sets up a picture where investors will be weighing these earnings against a 9.5% net margin and the impact of a one off gain...
NasdaqGM:URGN
NasdaqGM:URGNBiotechs

UroGen Pharma (URGN) Quarterly Loss Narrows To US$0.54 EPS Challenging Bearish Narratives

UroGen Pharma FY 2025 results set the stage for growth versus losses debate UroGen Pharma (URGN) closed out FY 2025 with Q4 revenue of US$37.8 million and a basic EPS loss of US$0.54, alongside a trailing twelve month loss of US$3.19 per share on US$109.8 million of revenue. The company has seen quarterly revenue move from US$24.6 million in Q4 2024 to US$37.8 million in Q4 2025. Over the same period, basic EPS ranged from a loss of US$1.05 in Q2 2025 to a loss of US$0.54 in the latest...
NYSE:BG
NYSE:BGFood

Is It Time To Reconsider Bunge Global (BG) After The Viterra Merger Re-Rating?

If you are wondering whether Bunge Global’s current share price lines up with its underlying worth, this article walks through the key numbers that matter for valuation. The stock recently closed at US$120.61, after a 0.6% decline over 7 days, a 5.9% gain over 30 days, and returns of 30.2% year to date, 73.1% over 1 year, 34.3% over 3 years, and 75.8% over 5 years. Recent coverage has focused on Bunge Global’s role in global agribusiness and food supply chains and how that positioning may...
NasdaqGS:QURE
NasdaqGS:QUREBiotechs

UniQure (QURE) Posts Q4 Loss Of US$37.1m Reinforcing Profitability Concerns

uniQure (QURE) has just wrapped up FY 2025 with fourth quarter revenue of US$5.6 million and a basic EPS loss of US$0.59, as net income excluding extra items came in at a loss of US$37.1 million. Over recent quarters, the company has seen revenue move between US$1.6 million and US$5.6 million while basic EPS ranged from a loss of US$0.59 to a loss of US$1.38. This gives investors a clear picture of a business that is still in heavy investment mode rather than focused on near term...
NasdaqGS:ALHC
NasdaqGS:ALHCHealthcare

Is It Time To Reassess Alignment Healthcare (ALHC) After Its Recent Share Price Swings

If you are wondering whether Alignment Healthcare is attractively priced at its current level, this article will walk through how the market might be valuing the stock today and what that could mean for you. The share price closed at US$19.65 recently, with returns of a 1.3% decline over the last week, a 12.8% decline over the last month, a 2.8% decline year to date, and a 26.6% gain over the past year, as well as a very large gain over three years. These moves have come alongside ongoing...
NasdaqCM:LMB
NasdaqCM:LMBConstruction

A Look At Limbach Holdings (LMB) Valuation After Strong 2025 Earnings And Recent Share Price Gains

Limbach Holdings (LMB) is back in focus after reporting fourth quarter and full year 2025 results, with higher sales, net income and earnings per share compared with the prior year periods. See our latest analysis for Limbach Holdings. The latest earnings release comes after a strong run in the shares, with a 90 day share price return of 29.7% and a 1 year total shareholder return of 15.65%. The 3 year total shareholder return is around 7x, and recent weekly moves have cooled short term...